Clinical Trial Update: A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of Tozorakimab injections versus placebo in adults with symptomatic chronic obstructive pulmona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tozorakimab (tozorakimab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING